• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非转移性结直肠癌手术患者随访的诊断率

Diagnostic yield of follow-up in patients undergoing surgery for non-metastatic colorectal cancer.

作者信息

Sala-Miquel Noelia, Carrasco-Muñoz José, Bernabeu-Mira Soledad, Mangas-Sanjuan Carolina, Baile-Maxía Sandra, Madero-Velázquez Lucía, Ausina Victor, Yuste Ana, Gómez-González Lucía, Romero Simó Manuel, Zapater Pedro, Jover Rodrigo

机构信息

Department of Gastroenterology, Hospital General Universitario Dr. Balmis, Alicante 03010, Valencia, Spain.

Department of Oncology, Hospital General Universitario Dr. Balmis, Alicante 03010, Valencia, Spain.

出版信息

World J Gastroenterol. 2025 Mar 28;31(12):100155. doi: 10.3748/wjg.v31.i12.100155.

DOI:10.3748/wjg.v31.i12.100155
PMID:40182602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11962849/
Abstract

BACKGROUND

Evidence on adherence, diagnostic performance and impact on survival to intensive follow-up after surgery for colorectal cancer (CRC) is limited.

AIM

To analyze the diagnostic performance of surveillance colonoscopy, computed tomography (CT), and tumor markers (TMs) in detecting CRC recurrence or metastasis during follow-up after CRC resection. Secondary objectives included degree of adherence to clinical practice guidelines surveillance recommendations and factors associated with adherence and all-cause and CRC mortality.

METHODS

The single-center retrospective cohort study including patients undergoing curative resection of stage I-III CRC during 2010-2015. Follow-up was performed using TMs every 6 months, yearly CT for 5 years, and colonoscopy at years 1 and 4. Demographic, primary tumor data, and results at follow-up were collected.

RESULTS

Of 574 included patients included, 153 had recurrences or metastases. Of this group, 136 (88.9%) were diagnosed by CT, 10 (6.5%) by CT and colonoscopy, and 7 (4.6%) by colonoscopy; only 67.8% showed TMs elevation. Adherence to follow-up recommendations was 68.8% for the first colonoscopy, 74% for the first CT scan, and 96.6% for the first blood test; these values declined over time. Younger age at diagnosis [odds ratio (OR) 0.93; 95%CI: 0.91-0.95], CRC stages I-II (OR 0.38; 95%CI: 0.24-0.61), and adherence to follow-up recommendations (OR 0.30; 95%CI: 0.20-0.46) were independently associated with lower risk for all-cause death at 5 years.

CONCLUSION

CT scan had the highest diagnostic yield. Adherence to follow-up recommendations was low and decreased during follow-up. Younger age at diagnosis, stage, and follow-up adherence were associated with lower 5-year mortality.

摘要

背景

关于结直肠癌(CRC)手术后强化随访的依从性、诊断性能及其对生存的影响的证据有限。

目的

分析结肠镜监测、计算机断层扫描(CT)和肿瘤标志物(TMs)在CRC切除术后随访期间检测CRC复发或转移的诊断性能。次要目标包括对临床实践指南监测建议的依从程度以及与依从性、全因死亡率和CRC死亡率相关的因素。

方法

这项单中心回顾性队列研究纳入了2010年至2015年期间接受I-III期CRC根治性切除的患者。每6个月使用TMs进行随访,连续5年每年进行CT检查,在第1年和第4年进行结肠镜检查。收集人口统计学、原发肿瘤数据以及随访结果。

结果

在纳入的574例患者中,153例出现复发或转移。在这组患者中,136例(88.9%)通过CT诊断,10例(6.5%)通过CT和结肠镜检查诊断,7例(4.6%)通过结肠镜检查诊断;只有67.8%的患者TMs升高。首次结肠镜检查的随访建议依从率为68.8%,首次CT扫描为74%,首次血液检查为96.6%;这些值随时间下降。诊断时年龄较小[比值比(OR)0.93;95%置信区间:0.91-0.95]、CRC I-II期(OR 0.38;95%置信区间:0.24-0.61)以及对随访建议的依从性(OR 0.30;95%置信区间:0.20-0.46)与5年全因死亡风险较低独立相关。

结论

CT扫描的诊断率最高。对随访建议的依从性较低且在随访期间下降。诊断时年龄较小、分期以及随访依从性与5年死亡率较低相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edc8/11962849/72b5f12ac343/100155-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edc8/11962849/5811f78aa924/100155-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edc8/11962849/72b5f12ac343/100155-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edc8/11962849/5811f78aa924/100155-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edc8/11962849/72b5f12ac343/100155-g002.jpg

相似文献

1
Diagnostic yield of follow-up in patients undergoing surgery for non-metastatic colorectal cancer.非转移性结直肠癌手术患者随访的诊断率
World J Gastroenterol. 2025 Mar 28;31(12):100155. doi: 10.3748/wjg.v31.i12.100155.
2
Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities.退伍军人健康管理局医疗机构中结直肠癌幸存者的计算机断层扫描监测模式。
Cancer. 2017 Jun 15;123(12):2338-2351. doi: 10.1002/cncr.30569. Epub 2017 Feb 17.
3
The majority of surgical departments adhere to national Danish guidelines for surveillance after colorectal cancer surgery.大多数外科科室遵循丹麦国家结直肠癌手术后监测指南。
Dan Med J. 2013 Jul;60(7):A4664.
4
Follow-Up Adherence After Treatment With Curative Intent for Stage II and III Colorectal Cancer Patients.II期和III期结直肠癌患者根治性治疗后的随访依从性
Cancer Med. 2025 Mar;14(5):e70667. doi: 10.1002/cam4.70667.
5
A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.一项随机对照试验,旨在评估对有治愈意图的结直肠癌切除术后患者进行强化随访与非定期随访的成本效益。
Health Technol Assess. 2017 May;21(32):1-86. doi: 10.3310/hta21320.
6
Yield of Surveillance Colonoscopies 1 Year After Curative Surgical Colorectal Cancer Resections.治愈性结直肠癌症手术后 1 年的监测结肠镜检查的结果。
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2285-2293. doi: 10.1016/j.cgh.2019.02.026. Epub 2019 Feb 22.
7
Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.专门的癌症中心监测计划对 II 期和 III 期结直肠癌患者遵循指南情况的影响。
Clin Colorectal Cancer. 2013 Jun;12(2):103-12. doi: 10.1016/j.clcc.2012.09.006. Epub 2012 Nov 13.
8
The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery.血清CA19-9定期检测在结直肠癌手术后监测中的作用。
Int J Clin Oncol. 2017 Feb;22(1):96-101. doi: 10.1007/s10147-016-1027-4. Epub 2016 Aug 8.
9
Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer.CT、FDG PET-CT及血清肿瘤标志物在复发性结直肠癌分期中的价值
Int J Comput Assist Radiol Surg. 2015 Jul;10(7):993-1002. doi: 10.1007/s11548-014-1115-8. Epub 2014 Sep 12.
10
Colonoscopic surveillance after curative colorectal resection: results of an empirical surveillance programme.结直肠癌根治性切除术后的结肠镜监测:一项经验性监测计划的结果
Colorectal Dis. 2003 May;5(3):233-40. doi: 10.1046/j.1463-1318.2003.00412.x.

引用本文的文献

1
Challenges in colorectal cancer post-surgical surveillance: A critical evaluation and path forward.结直肠癌术后监测的挑战:批判性评估与前进方向
World J Gastrointest Surg. 2025 Jun 27;17(6):106965. doi: 10.4240/wjgs.v17.i6.106965.
2
Personalized surveillance in colorectal cancer: Integrating circulating tumor DNA and artificial intelligence into post-treatment follow-up.结直肠癌的个性化监测:将循环肿瘤DNA和人工智能整合到治疗后随访中。
World J Gastroenterol. 2025 May 14;31(18):106670. doi: 10.3748/wjg.v31.i18.106670.

本文引用的文献

1
SEOM-GEMCAD-TTD clinical guidelines for the adjuvant treatment of colon cancer (2023).SEOM-GEMCAD-TTD 结肠癌辅助治疗临床指南(2023 年)。
Clin Transl Oncol. 2024 Nov;26(11):2812-2825. doi: 10.1007/s12094-024-03559-5. Epub 2024 Jun 24.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Six-Membered Aromatic Nitrogen Heterocyclic Anti-Tumor Agents: Synthesis and Applications.
六元含氮芳香杂环抗肿瘤剂:合成与应用。
Chem Rec. 2023 Dec;23(12):e202300293. doi: 10.1002/tcr.202300293. Epub 2023 Nov 27.
4
Methods and biomarkers for early detection, prediction, and diagnosis of colorectal cancer.结直肠癌的早期检测、预测和诊断方法及生物标志物。
Biomed Pharmacother. 2023 Jul;163:114786. doi: 10.1016/j.biopha.2023.114786. Epub 2023 Apr 27.
5
Adherence to surveillance colonoscopy guidelines in patients following curative-intent colorectal cancer resection.结直肠癌根治术后患者遵循结肠镜监测指南的情况。
Cancer Treat Res Commun. 2021;29:100479. doi: 10.1016/j.ctarc.2021.100479. Epub 2021 Oct 20.
6
Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences.循环肿瘤 DNA 在 III 期结直肠癌中的应用:超越微小残留病灶检测,评估辅助治疗疗效和复发的临床行为。
Clin Cancer Res. 2022 Feb 1;28(3):507-517. doi: 10.1158/1078-0432.CCR-21-2404. Epub 2021 Oct 8.
7
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.局限性结肠癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2020 Oct;31(10):1291-1305. doi: 10.1016/j.annonc.2020.06.022. Epub 2020 Jul 20.
8
Follow-up strategies for patients treated for non-metastatic colorectal cancer.非转移性结直肠癌患者的随访策略
Cochrane Database Syst Rev. 2019 Sep 4;9(9):CD002200. doi: 10.1002/14651858.CD002200.pub4.
9
Intensive follow-up strategies after radical surgery for nonmetastatic colorectal cancer: A systematic review and meta-analysis of randomized controlled trials.根治性手术后非转移性结直肠癌的强化随访策略:随机对照试验的系统评价和荟萃分析。
PLoS One. 2019 Jul 30;14(7):e0220533. doi: 10.1371/journal.pone.0220533. eCollection 2019.
10
Individualized eHealth Support for Oncological Therapy Management.肿瘤治疗管理的个性化电子健康支持
Breast Care (Basel). 2019 Jun;14(3):130-134. doi: 10.1159/000500900. Epub 2019 May 29.